Detailansicht

Wissensnetz

Person

Ralf Reilmann (1967-)

Neurologe

Name	Ralf Reilmann
Zeit	1967- (Lebensdaten)
Ort	Münster (Westf) (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Neurologe (charakteristischer Beruf)
Weitere Angaben	George-Huntington-Institut Münster
Quelle	orcid
Datensatztyp	Person
GND-Nummer	173092829
Datensatz-ID	173092829
Beteiligt an alle anzeigen Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trial Characterizing Patient-Reported Fatigue Using Electronic Diaries in Neurodegenerative and Immune-Mediated Inflammatory Diseases: Observational Study Empowering patients: A multimodal digital health technology survey of patients with neurogenerative disorders and immune-mediated inflammatory diseases Fatigue-Related Changes of Daily Function: Most Promising Measures for the Digital Age Anaplerotic Therapy Using Triheptanoin in Two Brothers Suffering from Aconitase 2 Deficiency Fatigue-Related Changes of Daily Function: Most Promising Measures for the Digital Age Differential diagnosis of chorea (guidelines of the German Neurological Society) Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society) Differential diagnosis of chorea (guidelines of the German Neurological Society) Technology acceptance of digital devices for home use: Qualitative results of a mixed methods study Effects of age and sex on outcomes of the Q-Motor speeded finger tapping and grasping and lifting tests-findings from the population-based BiDirect Study Huntington-Krankheit kompakt Physical activity and exercise outcomes in Huntington's disease (PACE-HD) : results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease Objectively characterizing Huntington’s disease using a novel upper limb dexterity test Correction to: Gait variability as digital biomarker of disease severity in Huntington’s disease Gait variability as digital biomarker of disease severity in Huntington’s disease Application of Quantitative Motor Assessments in Friedreich Ataxia and Evaluation of Their Relation to Clinical Measures Quantitative Measurements of Motor Function in Alzheimer’s Disease, Frontotemporal Dementia, and Dementia with Lewy Bodies: A Proof-of-Concept Study Leitlinien „Chorea/Morbus Huntington“ für die deutschsprachigen Länder neu überarbeitet M4 Safety and tolerability of BN82451B in huntington’s disease Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study Quantitative motor assessment of dyskinesias in Parkinson’s disease Compensation in preclinical Huntington's disease : : evidence from the track-on hd study Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study Creatine supplementation lowers brain glutamate levels in Huntington’s disease Huntingtonsche Krankheit : Veränderungen im Stoffwechsel neurotoxischer Aminosäuren ; Bestimmung der Aminosäuren Aspartat, Glutamat, Glutamin, Glycin und Phenylalanin in Thrombozyten und im Plasma und Messung der Aktivität der Enzyme GABA-Transaminase, Glutamat-Dehydrogenase, Glutamat-Oxalacetat-Transaminase und γ-Glutamyl-Transpeptidase [Gamma-Glutamyl-Transpeptidase] in Thrombozyten

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Ralf Reilmann (1967-)

Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trial

Characterizing Patient-Reported Fatigue Using Electronic Diaries in Neurodegenerative and Immune-Mediated Inflammatory Diseases: Observational Study

Empowering patients: A multimodal digital health technology survey of patients with neurogenerative disorders and immune-mediated inflammatory diseases

Fatigue-Related Changes of Daily Function: Most Promising Measures for the Digital Age

Anaplerotic Therapy Using Triheptanoin in Two Brothers Suffering from Aconitase 2 Deficiency

Fatigue-Related Changes of Daily Function: Most Promising Measures for the Digital Age

Differential diagnosis of chorea (guidelines of the German Neurological Society)

Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)

Differential diagnosis of chorea (guidelines of the German Neurological Society)

Technology acceptance of digital devices for home use: Qualitative results of a mixed methods study

Effects of age and sex on outcomes of the Q-Motor speeded finger tapping and grasping and lifting tests-findings from the population-based BiDirect Study

Huntington-Krankheit kompakt

Physical activity and exercise outcomes in Huntington's disease (PACE-HD) : results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease

Objectively characterizing Huntington’s disease using a novel upper limb dexterity test

Correction to: Gait variability as digital biomarker of disease severity in Huntington’s disease

Gait variability as digital biomarker of disease severity in Huntington’s disease

Application of Quantitative Motor Assessments in Friedreich Ataxia and Evaluation of Their Relation to Clinical Measures

Quantitative Measurements of Motor Function in Alzheimer’s Disease, Frontotemporal Dementia, and Dementia with Lewy Bodies: A Proof-of-Concept Study

Leitlinien „Chorea/Morbus Huntington“ für die deutschsprachigen Länder neu überarbeitet

M4 Safety and tolerability of BN82451B in huntington’s disease

Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study

Quantitative motor assessment of dyskinesias in Parkinson’s disease

Compensation in preclinical Huntington's disease : : evidence from the track-on hd study

Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study

Creatine supplementation lowers brain glutamate levels in Huntington’s disease